Intec Bioplastics, Inc.
OperatingSanta Monica, CA
Financials
FY2022–FY2024 · from SEC filings · hover any figure for its sourceFigures as reported by the issuer in the filing shown on hover. Each year’s pill shows the assurance level of its filed statements — audited, reviewed (CPA review, less than an audit), or unaudited; no pill means the filing didn’t state one. Headcount is the filing’s point-in-time count, not a year-end average. Manually corrected figures are marked “Corrected”.
Fundraising history
Team
3 peopleNames and titles as disclosed on SEC Form 1-A. Bios and photos come from the platform campaign page and may be out of date.
Reg CF annual-report compliance
never closed a Reg CF raise
Reg CF issuers must file a Form C-AR each year until a Rule 202(b) termination trigger is met.
SEC filings
- Form 1-UMay 20, 20260001096906-26-000835EDGAR
- Form 1-A/AFeb 19, 20260001096906-26-000240EDGAR
- Form 1-AJan 21, 20260001096906-26-000119EDGAR
- Form C/AAug 28, 20240001096906-24-001812EDGAR
- Form C/AAug 27, 20240001096906-24-001805EDGAR
- Form C/AAug 1, 20240001096906-24-001612EDGAR
- Form CJul 18, 20240001096906-24-001543EDGAR
About this data. Figures are compiled from public sources — SEC EDGAR filings (Form C, C-AR, 1-A, 1-K) and funding-platform pages — and may be delayed, incomplete, or restated by the issuer. Financial statements are as reported by the issuer; each year is labeled with its assurance level (audited / reviewed / unaudited). A valuation cap is the conversion ceiling of a SAFE or convertible note, not an agreed company valuation; post-money figures are computed as pre-money plus amount raised and are not a traded price. Crowdonomics is not a broker-dealer, funding portal, or investment adviser; nothing here is investment advice or an offer to sell securities. Verify all figures against the linked EDGAR filings.